2026 Cedars-Sinai GI and Surgery Symposium: Scopes, Scalpels and Science

This multidisciplinary gastroenterology surgery symposium is a comprehensive and cutting-edge conference designed to provide healthcare professionals with the latest advancements in gastroenterology, surgery, hepatology, and related fields. This annual event brings together leading experts to share their knowledge and insights across various subspecialties. This multi-day conference offers a diverse program covering key areas of gastroenterology and surgery: Inflammatory Bowel Disease (IBD), General Gastroenterology and Endoscopy, Hepatology and Motility, and general, foregut, colorectal, and pancreaticobiliary surgery. The conference will feature a mix of didactic lectures, interactive case discussions, and live-streamed procedures. Attendees will have ample opportunities to engage with faculty, participate in Q&A sessions, and network with colleagues. This educational meeting is designed for gastroenterologists, surgeons, internists, advanced practice providers, and other healthcare professionals involved in the care of patients with gastrointestinal and liver diseases and gastrointestinal and pancreaticobiliary surgery. It aims to provide practical, evidence-based information that can be immediately applied to clinical practice, ensuring attendees stay at the forefront of patient care in gastroenterology and gastrointestinal surgery.

1. Analyze recent advancements in IBD management.
2. Analyze recent innovations in endoscopic techniques.
3. Analyze updates in autoimmune liver disease management.
4. Critique emerging treatments for IBS and Eosinophilic Esophagitis.
5. Evaluate diagnostic and treatment strategies for gastroparesis.
6. Analyze recent developments in Barrett's esophagus and esophageal dysplasia management.
7. Evaluate medical and surgical management strategies of liver masses
8. Critique medical and surgical approaches to gastrointestinal polyp management
9. Evaluate early cancer detection and management in gastrointestinal malignancies
10. Analyze management approaches to viral and nonviral hepatitis

In-Person Fee

• Physician (In-person): $200

• Advanced Practice Provider (In-person): $150

• Student/Trainee (In-person): $25

• Industry (No Exhibit Booth): $500

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 10.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Andrea Banty, NP, DNP
Cedars Sinai

Course Director

Speaker-Johnson and Johnson|Advisor-Johnson and Johnson (Relationship has ended)|Speaker-Abbvie |Advisor-Genentech, Inc. (Relationship has ended)|Advisor-Merck and Company, Inc. (Relationship has ended)

Simon K. Lo, MD
Cedars-Sinai

Course Director

Consultant-Olympus Inc|Consultant-Boston Scientific Corporation

Gil Y. Melmed, MD
Cedars-Sinai

Course Director

Consultant-AbbVie|Advisor-Harp Diagnostics|Consultant-Viatris|Consultant-Fresenius Kabi|Stock Options or Shareholder-Nephroceuticals|Consultant-dieta|Consultant-Arena|Consultant-Bristol-Myers Squibb|Consultant-Boehringer Ingelheim Vetmedica GmbH|Consultant-Entasis (Relationship has ended)|Consultant-Medtronic, Inc.|Consultant-Johnson and Johnson|Other: Data safety monitoring board-Shionogi (Relationship has ended)|Consultant-Takeda Pharmaceuticals, Inc.|Consultant-Pfizer, Inc.|PrincipalNamedInvestigator-Pfizer, Inc.|PrincipalNamedInvestigator-Merck and Company, Inc.|Consultant-Techlab|Consultant-Ferring|Consultant-Samsung-Bioepis|Consultant-Oshi|Consultant-Prometheus Labs|Consultant-Eli Lilly and Company|Consultant-Genentech, Inc.|Consultant-OptionCare|Speaker-Abbvie|Speaker-Johnson and Johnson|Consultant-Diasorin|Consultant-Iterative Scopes|Consultant-Verantos

Edward Phillips, MD
Cedars Sinai Medical Center

Course Director

Nothing to disclose

Shelly C. Lu, MD
Cedars-Sinai

Planner

Nothing to disclose